Solid Tumor, Unspecified, Adult Clinical Trials

20 clinical trials for Solid Tumor, Unspecified, Adult across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values — RECRUITING · NA
• A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products — RECRUITING
• An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Gustave Roussy Cancer Profiling — RECRUITING · NA
• Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Psychotherapy Intervention for Latinos With Adv Cancer — RECRUITING · NA
• Psychotherapy Intervention for Latinos With Advanced Cancer — RECRUITING · NA
• AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. — RECRUITING · PHASE1
• Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment — RECRUITING
• UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations — NOT_YET_RECRUITING
• The Safety and Dosimetry Study of 177Lu-LNC1004 Injection — COMPLETED · PHASE1
• Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors — COMPLETED · PHASE1
• A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors — TERMINATED · PHASE1
• Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor — OTHER
• A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies — COMPLETED · PHASE1
• 68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors — OTHER · PHASE2
• RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors — COMPLETED · PHASE1
• Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein — COMPLETED
• Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair — COMPLETED · PHASE1

Refine this search